STRENSIQ

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Canada, Croatia, Estonia, Finland, France, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Romania, Turkey, UK.

Active ingredients

The drug STRENSIQ contains one active pharmaceutical ingredient (API):

1	Asfotase alfa UNII Z633861EIM - ASFOTASE ALFA
	Asfotase alfa, a human recombinant tissue-nonspecific alkaline phosphatase-Fc-deca-aspartate fusion protein with enzymatic activity, promotes mineralisation of the skeleton in patients with hypophosphatasia.
	Read more about Asfotase alfa

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
STRENSIQ Solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A16AB13		A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products → A16AB Enzymes
Discover more medicines within A16AB13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	565518120000201, 565518120000301, 565518120000401, 565518120000501
CA	Health Products and Food Branch	02444615, 02444623, 02444631, 02444658
EE	Ravimiamet	1696697, 1696709, 1696710, 1696721, 1696732, 1696743, 1696754, 1696765, 1696833, 1696844
FI	Lääkealan turvallisuus- ja kehittämiskeskus	035585, 071574, 183396, 586916
FR	Base de données publique des médicaments	64450234, 69258437
GB	Medicines & Healthcare Products Regulatory Agency	309303, 309306, 309309, 309315
IL	מִשְׂרַד הַבְּרִיאוּת	7975, 8372, 8373, 8374, 8375
IT	Agenzia del Farmaco	044478016, 044478028, 044478030, 044478042, 044478055, 044478067, 044478079, 044478081, 044478093, 044478105
JP	医薬品医療機器総合機構	3959418A1021, 3959418A2028, 3959418A3024, 3959418A4020, 3959418A5027
LT	Valstybinė vaistų kontrolės tarnyba	1078436, 1078437, 1078438, 1078439, 1078440, 1078441, 1078442, 1078443, 1078444, 1078445
PL	Rejestru Produktów Leczniczych	100354166, 100354172
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W69029001, W69029002, W69029003, W69029004, W69029005, W69029006, W69029007, W69029008, W69030001, W69030002
TR	İlaç ve Tıbbi Cihaz Kurumu	8680131470020, 8680131470037, 8680131470044, 8680131470051
US	FDA, National Drug Code	25682-010, 25682-013, 25682-016, 25682-019